Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension

NCT00657046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Intradialytic Hypotension

Interventions

DRUG: Droxidopa
DRUG: Placebo

Sponsor

Chelsea Therapeutics